SMS Lifesciences India
Sms Lifesciences India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in SMS Lifesciences India
Start SIPSms Lifesciences India Investment Rating
-
Master Rating:
-
Sms Lifesciences India has an operating revenue of Rs. 347.49 Cr. on a trailing 12-month basis. An annual revenue growth of 32% is outstanding, Pre-tax margin of 9% is okay, ROE of 16% is good. The company has a reasonable debt to equity of 26%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 111 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 91 | 78 | 80 | 95 |
| Operating Expenses Qtr Cr | 83 | 72 | 72 | 88 |
| Operating Profit Qtr Cr | 8 | 6 | 9 | 7 |
| Depreciation Qtr Cr | 2 | 2 | 2 | 2 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 1 | 1 | 2 | 2 |
| Net Profit Qtr Cr | 4 | 3 | 4 | 8 |
Sms Lifesciences India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹562.51
- 50 Day
- ₹561.15
- 100 Day
- ₹575.75
- 200 Day
- ₹606.64
- 20 Day
- ₹563.73
- 50 Day
- ₹549.59
- 100 Day
- ₹572.16
- 200 Day
- ₹618.86
Sms Lifesciences India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹562.99 |
| Second Resistance | ₹565.97 |
| Third Resistance | ₹569.94 |
| RSI | 48.5 |
| MFI | 90.27 |
| MACD Single Line | 4.42 |
| MACD | 2.29 |
| Support | |
|---|---|
| First Resistance | ₹556.04 |
| Second Resistance | ₹552.07 |
| Third Resistance | ₹549.09 |
Sms Lifesciences India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 1,145 | 77,894 | 68.03 |
| Week | 1,691 | 106,423 | 62.95 |
| 1 Month | 8,273 | 264,644 | 31.99 |
| 6 Month | 3,135 | 173,042 | 55.19 |
Sms Lifesciences India Result Highlights
SMS Lifesciences India Synopsis
NSE-Medical-Diversified
Sms Lifesciences Ind is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 345.63 Cr. and Equity Capital is Rs. 3.02 Cr. for the Year ended 31/03/2022. SMS Lifesciences India Ltd. is a Public Limited Listed company incorporated on 31/05/2006 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L74930TG2006PLC050223 and registration number is 050223.| Market Cap | 169 |
| Sales | 345 |
| Shares in Float | 0.09 |
| No of funds | 1 |
| Yield | 0.27 |
| Book Value | 1.12 |
| U/D Vol ratio | 2.9 |
| LTDebt / Equity | 18 |
| Alpha | -0.05 |
| Beta | 0.52 |
SMS Lifesciences India
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 70.32% | 70.32% | 69.86% | 69.85% |
| Foreign Portfolio Investors | ||||
| Individual Investors | 25.98% | 26.12% | 26.84% | 27.6% |
| Others | 3.7% | 3.56% | 3.3% | 2.55% |
SMS Lifesciences India Management
| Name | Designation |
|---|---|
| Mr. TVVSN Murthy | Managing Director |
| Mr. T V Praveen | Executive Director |
| Mrs. Sudeepthi Gopineedi | Whole Time Director |
| Mr. P Sarath Kumar | Independent Director |
| Mr. Srinivas Samavedam | Independent Director |
| Mr. Venkatasubbarao Potluri | Independent Director |
| Dr. Mannam Malakondaiah | Independent Director |
Sms Lifesciences India Forecast
Price Estimates
Sms Lifesciences India Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-29 | Audited Results & Dividend | |
| 2023-02-10 | Quarterly Results | |
| 2022-11-14 | Quarterly Results | |
| 2022-08-09 | Quarterly Results | |
| 2022-05-28 | Audited Results & Dividend |
SMS Lifesciences India FAQs
What is Share Price of SMS Lifesciences India ?
SMS Lifesciences India share price is ₹563 As on 28 May, 2023 | 04:21
What is the Market Cap of SMS Lifesciences India ?
The Market Cap of SMS Lifesciences India is ₹170.2 Cr As on 28 May, 2023 | 04:21
What is the P/E ratio of SMS Lifesciences India ?
The P/E ratio of SMS Lifesciences India is 9.4 As on 28 May, 2023 | 04:21
What is the PB ratio of SMS Lifesciences India ?
The PB ratio of SMS Lifesciences India is 1 As on 28 May, 2023 | 04:21